rs4680
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000754.4(COMT):c.472G>A(p.Val158Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,610,688 control chromosomes in the GnomAD database, including 197,380 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000754.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COMT | NM_000754.4 | c.472G>A | p.Val158Met | missense_variant | 4/6 | ENST00000361682.11 | NP_000745.1 | |
MIR4761 | NR_039918.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COMT | ENST00000361682.11 | c.472G>A | p.Val158Met | missense_variant | 4/6 | 1 | NM_000754.4 | ENSP00000354511 | P2 | |
MIR4761 | ENST00000585066.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.440 AC: 66834AN: 151946Hom.: 15493 Cov.: 33
GnomAD3 exomes AF: 0.461 AC: 114049AN: 247346Hom.: 27151 AF XY: 0.465 AC XY: 62409AN XY: 134140
GnomAD4 exome AF: 0.496 AC: 723171AN: 1458624Hom.: 181891 Cov.: 65 AF XY: 0.495 AC XY: 359427AN XY: 725604
GnomAD4 genome AF: 0.440 AC: 66839AN: 152064Hom.: 15489 Cov.: 33 AF XY: 0.440 AC XY: 32667AN XY: 74322
ClinVar
Submissions by phenotype
not specified Benign:5
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Schizophrenia Benign:1
Benign, criteria provided, single submitter | case-control | Center for Forensic Mental Health, Chiba University | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jan 01, 2011 | - - |
Tramadol response Other:1
drug response, no assertion criteria provided | research | Bruce Budowle Laboratory, University of North Texas Health Science Center | Apr 28, 2018 | - T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1 |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at